Structure

InChI Key NTJOBXMMWNYJFB-UHFFFAOYSA-N
Smile CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(N)cc1OC
InChI
InChI=1S/C17H27N3O4S/c1-4-20-8-6-7-12(20)11-19-17(21)13-9-16(25(22,23)5-2)14(18)10-15(13)24-3/h9-10,12H,4-8,11,18H2,1-3H3,(H,19,21)

Physicochemical Descriptors

Property Name Value
Molecular Formula C17H27N3O4S
Molecular Weight 369.49
AlogP 1.29
Hydrogen Bond Acceptor 6.0
Hydrogen Bond Donor 2.0
Number of Rotational Bond 7.0
Polar Surface Area 101.73
Molecular species NEUTRAL
Aromatic Rings 1.0
Heavy Atoms 25.0

Pharmacology

Action Mechanism of Action Reference
ANTAGONIST Dopamine receptors; D2 & D3 antagonist PubMed PubMed PubMed PubMed PubMed PubMed PubMed
Primary Target
D2 receptor

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Postoperative Nausea and Vomiting 4 D020250 FDA
Anxiety 3 D001007 ClinicalTrials
Dementia 3 D003704 ClinicalTrials
Schizophrenia 3 D012559 ClinicalTrials
Depressive Disorder 3 D003866 ClinicalTrials
Nausea 2 D009325 ClinicalTrials
Bipolar Disorder 2 D001714 ClinicalTrials
Depressive Disorder, Major 1 D003865 ClinicalTrials
Obsessive-Compulsive Disorder 1 D009771 ClinicalTrials
Renal Insufficiency, Chronic 1 D051436 ClinicalTrials
Anorexia Nervosa 0 D000856 ClinicalTrials

Related Entries

MCS

Scaffolds

Cross References

Resources Reference
CAS NUMBER 71675-85-9
ChEBI 64045
ChEMBL CHEMBL243712
DrugBank DB06288
DrugCentral 179
EPA CompTox DTXSID5042613
FDA SRS 8110R61I4U
Human Metabolome Database HMDB0015633
Guide to Pharmacology 963
PharmGKB PA162565877
PubChem 2159
SureChEMBL SCHEMBL34126